(NP (NP (NP (NP (NN Signaling)) (PP (IN by) (NP-COOD (NP (NN IL-2)) (CC and) (NP (JJ related) (NNS cytokines))))) (: :)) (NP-COOD (NP (NNS JAKs)) (, ,) (NP (NNS STATs)) (, ,) (CC and) (NP (NP (NN relationship)) (PP (TO to) (NP (NN immunodeficiency)))) (. .)))
(S (NP-SBJ (NP (NNS Cytokines)) (SBAR (WHNP-14 (WDT that)) (S (NP-SBJ (-NONE- *T*-14)) (VP (VBP bind) (PP (TO to) (NP (NP (DT the) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (NN receptor) (JJ common) (NP (NP (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gamma) (NN c)) (-RRB- -RRB-)))) (, ,) (PP (VBG including) (NP-COOD (NP (NN IL-2)) (, ,) (NP (NN IL-4)) (, ,) (NP (NN IL-7)) (, ,) (NP (NN IL-9)) (, ,) (CC and) (NP (NN IL-15)))) (, ,))))))) (VP (VBP are) (ADJP-PRD (JJ important) (PP (IN for) (NP (NP (DT the) (NP-COOD (NP (NN growth)) (CC and) (NP (NN differentiation)))) (PP (IN of) (NP-COOD (NP (NP-COOD (NP (NN T)) (CC and) (NP (NN B))) (NNS lymphocytes)) (, ,) (NP (JJ natural) (NN killer) (NNS cells)) (, ,) (NP (NNS macrophages)) (, ,) (CC and) (NP (NNS monoctyes)))))))) (. .))
(S (NP-SBJ (DT These) (NNS cytokines)) (VP (VBP have) (NP (NP (VBG overlapping) (JJ biological) (NNS effects)) (SBAR (WHNP-15 (WDT that)) (S (NP-SBJ (-NONE- *T*-15)) (VP (PP (IN in) (NP (NN part))) (VBP result) (PP (IN from) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (VBN shared) (NN receptor) (NN subunit) (NN gamma) (NN c)))))))))) (. .))
(S (ADVP-TMP (RB Recently)) (NP-SBJ (NP (PRP it)) (SBAR (-NONE- *EXP*-16))) (VP (VBZ has) (VP (VBN become) (ADJP-PRD (JJ clear)) (SBAR-16 (IN that) (S (NP-SBJ (DT these) (NNS cytokines)) (VP (VBP activate) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (JJ important) (JJ intracellular) (VBG signaling) (NNS molecules)) (, ,) (PP (VBG including) (NP-COOD (NP (DT the) (NN Janus) (NNS kinases) (NP-COOD (NP (NN JAK1)) (CC and) (NP (NN JAK3)))) (CC and) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NN transcription) (NN factor) (NN family)) (PP (IN of) (NP (NP (NP (NN signal) (NP-COOD (NP (NNS transducers)) (CC and) (NP (NNS activators)))) (PP (IN of) (NP (NN transcription)))) (PRN (-LRB- -LRB-) (NP (NNS STATs)) (-RRB- -RRB-))))))))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN discovery)) (PP (IN of) (NP (DT these) (NN signaling) (NNS pathways)))) (VP (VBZ has) (VP (VBN led) (PP (TO to) (NP (NP (JJ important) (JJ new) (NNS insights)) (PP (IN into) (NP (NP (PRP$ their) (NN role)) (PP (IN in) (NP (NN lymphocyte) (NN maturation))))))) (, ,) (SBAR (IN as) (S (NP-SBJ (NP (PRP it)) (SBAR (-NONE- *EXP*-17))) (VP (VBZ has) (VP (VBN emerged) (SBAR-17 (IN that) (S (NP-SBJ (NP (NNS mutations)) (PP (IN in) (NP (NP (DT the) (NNS genes)) (VP (VBG encoding) (NP-COOD (CC both) (NP (NN gamma) (NN c)) (CC and) (NP (NN JAK3))))))) (VP (VBP result) (PP (IN in) (NP (NP (JJ similar) (NNS forms)) (PP (IN of) (NP (NP (JJ severe) (JJ combined) (NN immunodeficiency)) (PRN (-LRB- -LRB-) (NP (NN SCID)) (-RRB- -RRB-))))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN review))) (NP-SBJ (PRP we)) (VP (VBP examine) (NP-COOD (NP (NP (DT the) (NP-COOD (NP (NN structure)) (CC and) (NP (NN function)))) (PP (IN of) (NP (NN cytokine) (NNS receptors)))) (CC and) (NP (NP (DT the) (NN signaling) (NNS pathways)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NP (PRP$ their) (NN regulation)) (PP (IN of) (NP (NN gene) (NN expression))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (PRP we)) (VP (VBP discuss) (NP (NP (JJ recent) (NNS advances)) (SBAR (WHNP-18 (WDT that)) (S (NP-SBJ (-NONE- *T*-18)) (VP (VBP have) (VP (VBN led) (PP (TO to) (NP (NP (DT a) (JJR better) (NN understanding)) (PP (IN of) (SBAR (WHADVP-19 (WRB how)) (S (NP-SBJ (NNS cytokines)) (VP (VBP elicit) (NP (JJ intracellular) (NNS responses)) (, ,) (PP (RB as) (RB well) (IN as) (NP (NP (PRP$ their) (NN role)) (PP (IN in) (NP (JJ normal) (JJ lymphoid) (NN development))))) (ADVP (-NONE- *T*-19)))))))))))))) (. .))
